Real-world study of effectiveness and safety compared among isavuconazole, amphotericin B, and voriconazole in invasive mold disease patients. (PubMed, Eur J Clin Microbiol Infect Dis) - Jul 24, 2026 - "In this retrospective cohort, ISA was associated with lower adjusted mortality than VCZ. ISA associated with favorable clinical outcomes and an acceptable safety profile in real-world IMD practice."
Journal • Real-world evidence
|
|
Feng Ye; Shao-Qiang Li; Wu-Shu Chen; Yan Wang; Yang-Qing Zhan; Ye Qiu; Zheng-Tu Li
|